Brokerages Set Stericycle, Inc. (NASDAQ:SRCL) PT at $74.00

Stericycle, Inc. (NASDAQ:SRCL) has earned an average recommendation of “Hold” from the six analysts that are covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the company. The average 12-month target price among brokers that have issued a report on the stock in the last year is $74.00.

A number of equities research analysts have recently commented on the company. Robert W. Baird dropped their price target on Stericycle from $62.00 to $55.00 and set a “neutral” rating on the stock in a research report on Friday, April 26th. Truist Financial raised their price target on Stericycle from $50.00 to $62.00 and gave the stock a “hold” rating in a research report on Tuesday, June 4th. Keefe, Bruyette & Woods raised their price target on Stericycle from $135.00 to $142.00 and gave the stock an “outperform” rating in a research report on Tuesday, June 4th. StockNews.com started coverage on Stericycle in a research report on Monday. They set a “hold” rating on the stock. Finally, Royal Bank of Canada reissued a “sector perform” rating and issued a $62.00 target price (down previously from $69.00) on shares of Stericycle in a research report on Tuesday, June 4th.

Stericycle Trading Down 0.0 %

NASDAQ:SRCL opened at $58.13 on Wednesday. Stericycle has a 1-year low of $37.78 and a 1-year high of $59.45. The business’s 50-day moving average price is $54.48 and its two-hundred day moving average price is $51.51. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.55. The firm has a market capitalization of $5.40 billion, a price-to-earnings ratio of -264.23, a PEG ratio of 3.14 and a beta of 1.11.

Stericycle (NASDAQ:SRCL) last released its earnings results on Thursday, April 25th. The business services provider reported $0.57 earnings per share for the quarter, beating the consensus estimate of $0.54 by $0.03. The firm had revenue of $664.90 million for the quarter, compared to analyst estimates of $676.42 million. Stericycle had a positive return on equity of 7.31% and a negative net margin of 0.74%. The company’s quarterly revenue was down 2.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.49 earnings per share. On average, equities analysts expect that Stericycle will post 2.32 earnings per share for the current year.

Institutional Investors Weigh In On Stericycle

Hedge funds and other institutional investors have recently bought and sold shares of the company. Retirement Systems of Alabama increased its holdings in shares of Stericycle by 0.3% during the 1st quarter. Retirement Systems of Alabama now owns 116,185 shares of the business services provider’s stock worth $6,129,000 after acquiring an additional 305 shares during the last quarter. Strategic Blueprint LLC increased its holdings in shares of Stericycle by 6.2% during the 4th quarter. Strategic Blueprint LLC now owns 5,609 shares of the business services provider’s stock worth $278,000 after acquiring an additional 326 shares during the last quarter. Raymond James Financial Services Advisors Inc. increased its holdings in shares of Stericycle by 4.9% during the 4th quarter. Raymond James Financial Services Advisors Inc. now owns 7,243 shares of the business services provider’s stock worth $359,000 after acquiring an additional 336 shares during the last quarter. Treasurer of the State of North Carolina increased its holdings in shares of Stericycle by 1.0% during the 4th quarter. Treasurer of the State of North Carolina now owns 40,838 shares of the business services provider’s stock worth $2,024,000 after acquiring an additional 400 shares during the last quarter. Finally, Blue Trust Inc. increased its holdings in shares of Stericycle by 15.4% during the 4th quarter. Blue Trust Inc. now owns 3,125 shares of the business services provider’s stock worth $155,000 after acquiring an additional 416 shares during the last quarter. Institutional investors and hedge funds own 98.82% of the company’s stock.

About Stericycle

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.